{
    "nctId": "NCT06435546",
    "briefTitle": "Adherence to Oral Therapies in Advanced Breast and Prostate Cancers",
    "officialTitle": "Adherence to Oral Therapies in Advanced Breast and Prostate Cancers: a Pilot Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Prostate Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Assess medication adherence to oral treatments in patients with advanced breast or prostate cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult over 18 years old.\n* Patient with inoperable advanced breast cancer treated with oral endocrine therapy and/or targeted therapy and patient with inoperable advanced prostate cancer treated with oral hormonal therapy and/or targeted therapy.\n* Oral anticancer medications started for at least 3 months.\n* With a performance status \u2264 3.\n* Patient has understood, signed and dated the consent form.\n* Patient covered by the social security system.\n\nExclusion Criteria:\n\n* Patient with early breast cancer or localized prostate cancer.\n* Patient with life expectancy \\< 3 months.\n* Patient in progression\n* Undergoing intravenous or oral cytotoxic chemotherapy (capecitabine, cyclophosphamide, vinorelbine).\n* Patient who has not yet started oral anticancer therapies or who has started for less than 3 months.\n* Patient unable to read or speak French.\n* Patient already included in another therapeutic trial with an experimental molecule.\n* Persons deprived of their liberty or under guardianship (including curatorship).",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}